{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Hepcidin", "anemia", "iron deficiency", "peptide hormone"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36317954", "DateRevised": {"Year": "2022", "Month": "11", "Day": "18"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.4274/tjps.galenos.2021.29488"], "Journal": {"ISSN": "2148-6247", "JournalIssue": {"Volume": "19", "Issue": "5", "PubDate": {"Year": "2022", "Month": "Oct", "Day": "31"}}, "Title": "Turkish journal of pharmaceutical sciences", "ISOAbbreviation": "Turk J Pharm Sci"}, "ArticleTitle": "Hepcidin as a Potential Biomarker for the Diagnosis of Anemia.", "Pagination": {"StartPage": "603", "EndPage": "609", "MedlinePgn": "603-609"}, "Abstract": {"AbstractText": ["There are several blood-based markers to assess iron stores, but they all have some limitations. Hepcidin, a low-molecular-weight peptide hormone, is produced mainly by the liver. It is the main regulator of iron homeostasis by preventing iron release into plasma from absorptive enterocytes and macrophages. This review aims to critically assess existing data on potential role of hepcidin in diagnosis, particularly the (pre) analytical implications of the hepcidin measurement. There is a well-known causative correlation between hepcidin and iron deficiency. Therefore, hepcidin is considered as a promising marker in the assessment of iron status, particularly in patients with a diagnostic dilemma, such as patients with chronic renal disease and infants. The clinical implications of this peptide hormone in diagnosis of other diseases have been expanded in the recent studies, including elevated hepcidin levels in neoplastic diseases, sepsis, and inflammation. The potential role of hepcidin in diagnosis is controversial in the various types of iron deficiency because data are conflicting (as in anaemia of chronic disease) or limited (as in infants), whereas in the case of hereditary haemochromatosis, it has been proposed that hepcidin may be used for stratification of molecular testing, or to improve the frequency of phlebotomy, however, this issue still needs to be investigated. Due to lack of a clinically approved test, the medical application of this peptide as a biomarker in diagnosis is restricted. Recently, assays have been developed to determine hepcidin levels in serum and urine, facilitating the future use of hepcidin in research and clinical practice."], "CopyrightInformation": "\u00a9Turk J Pharm Sci, Published by Galenos Publishing House."}, "AuthorList": [{"Identifier": ["0000-0003-0327-0914"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University of Mosul, College of Pharmacy, Department of Pharmacognosy and Medicinal Plants, Mosul, Iraq."}], "LastName": "Fathi", "ForeName": "Zainab H", "Initials": "ZH"}, {"Identifier": ["0000-0001-6831-7619"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University of Mosul, College of Pharmacy, Department of Pharmacognosy and Medicinal Plants, Mosul, Iraq."}], "LastName": "Mohammad", "ForeName": "Jehan A", "Initials": "JA"}, {"Identifier": ["0000-0002-1820-3346"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University of Mosul, College of Pharmacy, Department of Pharmacognosy and Medicinal Plants, Mosul, Iraq."}], "LastName": "Younus", "ForeName": "Zaid M", "Initials": "ZM"}, {"Identifier": ["0000-0002-6184-0447"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University of Mosul, College of Pharmacy, Department of Pharmacognosy and Medicinal Plants, Mosul, Iraq."}], "LastName": "Mahmood", "ForeName": "Sameer M", "Initials": "SM"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Turkey", "MedlineTA": "Turk J Pharm Sci", "NlmUniqueID": "101717890", "ISSNLinking": "1304-530X"}, "CoiStatement": "Conflict of Interest: No conflict of interest was declared by the authors."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Kali A, Charles MV, Seetharam RS. Hepcidin - a novel biomarker with changing trends. Pharmacogn Rev. 2015;9:35\u201340.", "ArticleIdList": ["PMC4441160", "26009691"]}, {"Citation": "Nicolae CD, Coman OA, Ene C, Nicolae I, Fulga I. Hepcidin in neoplastic disease. J Med Life. 2013;6:355\u2013360.", "ArticleIdList": ["PMC3786499", "24146699"]}, {"Citation": "Reichert C, Marafon F, Levy D, Maselli L, Bagatini M, Blatt S, Bydlowski S, Celso S. In book: Current Topics in Anemia, Intechopen. Edited by Jesmine Khan. 2018."}, {"Citation": "Girelli D, Nemeth E, Swinkels DW. Hepcidin in the diagnosis of iron disorders. Blood. 2016;127:2809\u20132813.", "ArticleIdList": ["PMC4956612", "27044621"]}, {"Citation": "Pagani A, Nai A, Silvestri L, Camaschella C. Hepcidin and anemia: a tight relationship. Front Physiol. 2019;10:1294.", "ArticleIdList": ["PMC6794341", "31649559"]}, {"Citation": "D\u2019Angelo G. Role of hepcidin in the pathophysiology and diagnosis of anemia. Blood Res. 2013;48:10\u201315.", "ArticleIdList": ["PMC3624997", "23589789"]}, {"Citation": "Robson KJ. Hepcidin and its role in iron absorption. Gut. 2004;53:617\u2013619.", "ArticleIdList": ["PMC1774051", "15082573"]}, {"Citation": "Fleming RE, Sly WS. Hepcidin: a putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease. Proc Natl Acad Sci U S A. 2001;98:8160\u20138162.", "ArticleIdList": ["PMC37412", "11459944"]}, {"Citation": "Ganz T, Nemeth E. Iron imports. IV. Hepcidin and regulation of body iron metabolism. Am J Physiol Gastrointest Liver Physiol. 2006;290:G199\u2013203.", "ArticleIdList": ["16407589"]}, {"Citation": "Ashrafian H. Hepcidin: the missing link between hemochromatosis and infections. Infect Immun. 2003;71:6693\u20136700.", "ArticleIdList": ["PMC308925", "14638752"]}, {"Citation": "Lasocki S, Longrois D, Montravers P, Beaumont C. Hepcidin and anemia of the critically ill patient: bench to bedside. Anesthesiology. 2011;114:688\u2013694.", "ArticleIdList": ["21258235"]}, {"Citation": "Cizmeci MN, Kara S, Kanburoglu MK, Simavli S, Duvan CI, Tatli MM. Detection of cord blood hepcidin levels as a biomarker for early-onset neonatal sepsis. Med Hypotheses. 2014;82:310\u2013312.", "ArticleIdList": ["24424393"]}, {"Citation": "Dudkowiak R, Neubauer K, Poniewierka E. Hepcidin and its role in inflammatory bowel disease. Adv Clin Exp Med. 2013;22:585\u2013591.", "ArticleIdList": ["23986220"]}, {"Citation": "Kemna EH, Tjalsma H, Willems HL, Swinkels DW. Hepcidin: from discovery to differential diagnosis. Haematologica. 2008;93:90\u201397.", "ArticleIdList": ["18166790"]}, {"Citation": "Piperno A, Mariani R, Trombini P, Girelli D. Hepcidin modulation in human diseases: from research to clinic. World J Gastroenterol. 2009;15:538\u2013551.", "ArticleIdList": ["PMC2653344", "19195055"]}, {"Citation": "Camaschella C, Silvestri L. Molecular mechanisms regulating hepcidin revealed by hepcidin disorders. Sci World J. 2011;11:1357\u20131366.", "ArticleIdList": ["PMC5720007", "21789471"]}, {"Citation": "Ganz T, Olbina G, Girelli D, Nemeth E, Westerman M. Immunoassay for human serum hepcidin. Blood. 2008;112:4292\u20134297.", "ArticleIdList": ["18689548"]}, {"Citation": "Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood. 2003;101:2461\u20132463.", "ArticleIdList": ["12433676"]}, {"Citation": "Kemna E, Pickkers P, Nemeth E, van der Hoeven H, Swinkels D. Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood. 2005;106:1864\u20131866.", "ArticleIdList": ["15886319"]}, {"Citation": "Brugnara C. An immunoassay for human serum hepcidin at last: Ganz klar? Blood. 2008;112:3922\u20133923.", "ArticleIdList": ["18988874"]}, {"Citation": "Brugnara C. Iron deficiency and erythropoiesis: new diagnostic approaches. Clin Chem. 2003;49:1573\u20131578.", "ArticleIdList": ["14500582"]}, {"Citation": "Lozoff B, Jimenez E, Wolf AW. Long-term developmental outcome of infants with iron deficiency. N Engl J Med. 1991;325:687\u2013694.", "ArticleIdList": ["1870641"]}, {"Citation": "Brugnara C, Zurakowski D, DiCanzio J, Boyd T, Platt O. Reticulocyte hemoglobin content to diagnose iron deficiency in children. JAMA. 1999;281:2225\u20132230.", "ArticleIdList": ["10376576"]}, {"Citation": "De Falco L, Totaro F, Nai A, Pagani A, Girelli D, Silvestri L, Piscopo C, Campostrini N, Dufour C, Al Manjomi F, Minkov M, Van Vuurden DG, Feliu A, Kattamis A, Camaschella C, Iolascon A. Novel TMPRSS6 mutations associated with iron-refractory iron deficiency anemia (IRIDA) Hum Mutat. 2010;31:E1390\u20131405.", "ArticleIdList": ["20232450"]}, {"Citation": "Beutler E, Van Geet C, te Loo DM, Gelbart T, Crain K, Truksa J, Lee PL. Polymorphisms and mutations of human TMPRSS6 in iron deficiency anemia. Blood Cells Mol Dis. 2010;44:16\u201321.", "ArticleIdList": ["PMC2818284", "19818657"]}, {"Citation": "Theurl I, Aigner E, Theurl M, Nairz M, Seifert M, Schroll A, Sonnweber T, Eberwein L, Witcher DR, Murphy AT, Wroblewski VJ, Wurz E, Datz C, Weiss G. Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. Blood. 2009;113:5277\u20135286.", "ArticleIdList": ["19293425"]}, {"Citation": "Tiker F, Celik B, Tarcan A, Kilicdag H, Ozbek N, Gurakan B. Serum pro-hepcidin levels and relationships with iron parameters in healthy preterm and term newborns. Pediatr Hematol Oncol. 2006;23:293\u2013297.", "ArticleIdList": ["16621770"]}, {"Citation": "Ulukol B, Orhon FS, Hanoluk A, Akar N. Serum pro-hepcidin levels and relationship with ferritin in healthy non-anaemic infants. Acta Haematol. 2007;118:70\u201372.", "ArticleIdList": ["17536187"]}, {"Citation": "Orhon FS, Ulukol B, Hanoluk A, Akar N. Serum pro-hepcidin levels in infants with iron deficiency anaemia. Int J Lab Hematol. 2008;30:546\u2013547.", "ArticleIdList": ["18983309"]}, {"Citation": "Collard KJ. Iron homeostasis in the neonate. Pediatrics. 2009;123:1208\u20131216.", "ArticleIdList": ["19336381"]}, {"Citation": "Karlsson T. Evaluation of a competitive hepcidin ELISA assay in the differential diagnosis of iron deficiency anaemia with concurrent inflammation and anaemia of inflammation in elderly patients. J Inflamm (Lond). 2017;14:21.", "ArticleIdList": ["PMC5604302", "28936123"]}, {"Citation": "Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352:1011\u20131023.", "ArticleIdList": ["15758012"]}, {"Citation": "Kemna EH, Kartikasari AE, van Tits LJ, Pickkers P, Tjalsma H, Swinkels DW. Regulation of hepcidin: insights from biochemical analyses on human serum samples. Blood Cells Mol Dis. 2008;40:339\u2013346.", "ArticleIdList": ["18023212"]}, {"Citation": "Weiss G, Ganz T, Goodnough LT. Anemia of inflammation. Blood. 2019;133:40\u201350.", "ArticleIdList": ["PMC6536698", "30401705"]}, {"Citation": "Koliaraki V, Marinou M, Vassilakopoulos TP, Vavourakis E, Tsochatzis E, Pangalis GA, Papatheodoridis G, Stamoulakatou A, Swinkels DW, Papanikolaou G, Mamalaki A. A novel immunological assay for hepcidin quantification in human serum. PLoS One. 2009;4:e4581.", "ArticleIdList": ["PMC2640459", "19238200"]}, {"Citation": "Yacoub MF, Ferwiz HF, Said F. Effect of interleukin and hepcidin in anemia of chronic diseases. Anemia. 2020;2020:3041738.", "ArticleIdList": ["PMC7033950", "32095285"]}, {"Citation": "Lasocki S, Baron G, Driss F, Westerman M, Puy H, Boutron I, Beaumont C, Montravers P. Diagnostic accuracy of serum hepcidin for iron deficiency in critically ill patients with anemia. Intensive Care Med. 2010;36:1044\u20131048.", "ArticleIdList": ["20213069"]}, {"Citation": "Cherian S, Forbes DA, Cook AG, Sanfilippo FM, Kemna EH, Swinkels DW, Burgner DP. An insight into the relationships between hepcidin, anemia, infections and inflammatory cytokines in pediatric refugees: a crosssectional study. PLoS One. 2008;3:e4030.", "ArticleIdList": ["PMC2603326", "19107209"]}, {"Citation": "Thomas C, Kobold U, Balan S, Roeddiger R, Thomas L. Serum hepcidin-25 may replace the ferritin index in the Thomas plot in assessing iron status in anemic patients. Int J Lab Hematol. 2011;33:187\u201393.", "ArticleIdList": ["20868446"]}, {"Citation": "Donker AE, Schaap CC, Novotny VM, Smeets R, Peters TM, van den Heuvel BL, Raphael MF, Rijneveld AW, Appel IM, Vlot AJ, Versluijs AB, van Gelder M, Granzen B, Janssen MC, Rennings AJ, van de Veerdonk FL, Brons PP, Bakkeren DL, Nijziel MR, Vlasveld LT, Swinkels DW. Iron refractory iron deficiency anemia: a heterogeneous disease that is not always iron refractory. Am J Hematol. 2016;91:E482\u2013E490.", "ArticleIdList": ["PMC6586001", "27643674"]}, {"Citation": "Heeney MM, Guo D, De Falco L, Campagna DR, Olbina G, Kao PP, Schmitz-Abe K, Rahimov F, Gutschow P, Westerman K, Ostland V, Jackson T, Klaassen RJ, Markianos K, Finberg KE, Iolascon A, Westerman M, London WB, Fleming MD. Normalizing hepcidin predicts TMPRSS6 mutation status in patients with chronic iron deficiency. Blood. 2018;132:448\u2013452. Erratum in: Blood. 2018;132:1355.", "ArticleIdList": ["PMC6071554", "29895660"]}, {"Citation": "S\u00f8rensen E, Rigas AS, Didriksen M, Burgdorf KS, Th\u00f8rner LW, Pedersen OB, Hjalgrim H, Petersen MS, Erikstrup C, Ullum H. Genetic factors influencing hemoglobin levels in 15,567 blood donors: results from the danish blood donor study. Transfusion. 2019;59:226\u2013231.", "ArticleIdList": ["30536387"]}, {"Citation": "Brugnara C, Colella GM, Cremins J, Langley RC Jr, Schneider TJ, Rutherford CJ, Goldberg MA. Effects of subcutaneous recombinant human erythropoietin in normal subjects: development of decreased reticulocyte hemoglobin content and iron-deficient erythropoiesis. J Lab Clin Med. 1994;123:660\u2013667.", "ArticleIdList": ["8195672"]}, {"Citation": "Coyne D. Iron indices: what do they really mean? Kidney Int Suppl. 2006:S4\u20138.", "ArticleIdList": ["16830699"]}, {"Citation": "Katodritou E, Zervas K, Terpos E, Brugnara C. Use of erythropoiesis stimulating agents and intravenous iron for cancer and treatment-related anaemia: the need for predictors and indicators of effectiveness has not abated. Br J Haematol. 2008;142:3\u201310.", "ArticleIdList": ["18430192"]}, {"Citation": "Wish JB. Assessing iron status: beyond serum ferritin and transferrin saturation. Clin J Am Soc Nephrol. 2006;1 (Suppl 1):S4\u20138.", "ArticleIdList": ["17699374"]}, {"Citation": "Nakanishi T, Kimura T, Kuragano T. The hepcidin-anemia axis: pathogenesis of anemia in chronic kidney disease. Contrib Nephrol. 2019;198:124\u2013134.", "ArticleIdList": ["30991414"]}, {"Citation": "Li H, Rose MJ, Tran L, Zhang J, Miranda LP, James CA, Sasu BJ. Development of a method for the sensitive and quantitative determination of hepcidin in human serum using LC-MS/MS. J Pharmacol Toxicol Methods. 2009;59:171\u2013180.", "ArticleIdList": ["19258043"]}, {"Citation": "Ashby DR, Gale DP, Busbridge M, Murphy KG, Duncan ND, Cairns TD, Taube DH, Bloom SR, Tam FW, Chapman RS, Maxwell PH, Choi P. Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease. Kidney Int. 2009;75:976\u2013981.", "ArticleIdList": ["19212416"]}, {"Citation": "Zaritsky J, Young B, Wang HJ, Westerman M, Olbina G, Nemeth E, Ganz T, Rivera S, Nissenson AR, Salusky IB. Hepcidin--a potential novel biomarker for iron status in chronic kidney disease. Clin J Am Soc Nephrol. 2009;4:1051\u20131056.", "ArticleIdList": ["PMC2689881", "19406957"]}, {"Citation": "Babitt JL, Lin HY. Molecular mechanisms of hepcidin regulation: implications for the anemia of CKD. Am J Kidney Dis. 2010;55:726\u2013741.", "ArticleIdList": ["PMC2905036", "20189278"]}, {"Citation": "Peters HP, Laarakkers CM, Swinkels DW, Wetzels JF. Serum hepcidin-25 levels in patients with chronic kidney disease are independent of glomerular filtration rate. Nephrol Dial Transplant. 2010;25:848\u2013853.", "ArticleIdList": ["19854845"]}, {"Citation": "Weiss G, Theurl I, Eder S, Koppelstaetter C, Kurz K, Sonnweber T, Kobold U, Mayer G. Serum hepcidin concentration in chronic haemodialysis patients: associations and effects of dialysis, iron and erythropoietin therapy. Eur J Clin Invest. 2009;39:883\u2013890.", "ArticleIdList": ["19563467"]}, {"Citation": "Kato A, Tsuji T, Luo J, Sakao Y, Yasuda H, Hishida A. Association of prohepcidin and hepcidin-25 with erythropoietin response and ferritin in hemodialysis patients. Am J Nephrol. 2008;28:115\u2013121.", "ArticleIdList": ["17943020"]}, {"Citation": "Costa E, Swinkels DW, Laarakkers CM, Rocha-Pereira P, Rocha S, Reis F, Teixeira F, Miranda V, do Sameiro Faria M, Loureiro A, Quintanilha A, Belo L, Santos-Silva A. Hepcidin serum levels and resistance to recombinant human erythropoietin therapy in haemodialysis patients. Acta Haematol. 2009;122:226\u2013229.", "ArticleIdList": ["19887781"]}, {"Citation": "Swinkels DW, Wetzels JF. Hepcidin: a new tool in the management of anaemia in patients with chronic kidney disease? Nephrol Dial Transplant. 2008;23:2450\u20132453.", "ArticleIdList": ["18495744"]}, {"Citation": "Swinkels DW, Drenth JP. Hepcidin in the management of patients with mild non-hemochromatotic iron overload: Fact or fiction? J Hepatol. 2008;49:680\u2013685.", "ArticleIdList": ["18804889"]}, {"Citation": "Alexander J, Kowdley KV. HFE-associated hereditary hemochromatosis. Genet Med. 2009;11:307\u2013313.", "ArticleIdList": ["19444013"]}, {"Citation": "Swinkels DW, Janssen MC, Bergmans J, Marx JJ. Hereditary hemochromatosis: genetic complexity and new diagnostic approaches. Clin Chem. 2006;52:950\u2013968.", "ArticleIdList": ["16627556"]}, {"Citation": "Nemeth E. Hepcidin in beta-thalassemia. Ann N Y Acad Sci. 2010;1202:31\u201335.", "ArticleIdList": ["PMC2924878", "20712769"]}, {"Citation": "European Association for The Study of The Liver. EASL clinical practice guidelines for HFE hemochromatosis. J Hepatol. 2010;53:3\u201322.", "ArticleIdList": ["20471131"]}, {"Citation": "Piperno A, Girelli D, Nemeth E, Trombini P, Bozzini C, Poggiali E, Phung Y, Ganz T, Camaschella C. Blunted hepcidin response to oral iron challenge in HFE-related hemochromatosis. Blood. 2007;110:4096\u20134100.", "ArticleIdList": ["17724144"]}, {"Citation": "Bozzini C, Campostrini N, Trombini P, Nemeth E, Castagna A, Tenuti I, Corrocher R, Camaschella C, Ganz T, Olivieri O, Piperno A, Girelli D. Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis. Blood Cells Mol Dis. 2008;40:347\u2013352.", "ArticleIdList": ["18164223"]}, {"Citation": "Cheng Z, Yan M, Lu Y, Pan XT. Expression of serum BMP6 and hepcidin in cancer-related anemia. Hematology. 2020;25:134\u2013138.", "ArticleIdList": ["32153255"]}, {"Citation": "Hunter HN, Fulton DB, Ganz T, Vogel HJ. The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis. J Biol Chem. 2002;277:37597\u201337603.", "ArticleIdList": ["12138110"]}, {"Citation": "Kroot JJ, Laarakkers CM, Geurts-Moespot AJ, Grebenchtchikov N, Pickkers P, van Ede AE, Peters HP, van Dongen-Lases E, Wetzels JF, Sweep FC, Tjalsma H, Swinkels DW. Immunochemical and massspectrometry- based serum hepcidin assays for iron metabolism disorders. Clin Chem. 2010;56:1570\u20131579.", "ArticleIdList": ["20739637"]}, {"Citation": "Kroot JJ, van Herwaarden AE, Tjalsma H, Jansen RT, Hendriks JC, Swinkels DW. Second round robin for plasma hepcidin methods: first steps toward harmonization. Am J Hematol. 2012;87:977\u2013983.", "ArticleIdList": ["22886770"]}, {"Citation": "van der Vorm LN, Hendriks JC, Laarakkers CM, Klaver S, Armitage AE, Bamberg A, Geurts-Moespot AJ, Girelli D, Herkert M, Itkonen O, Konrad RJ, Tomosugi N, Westerman M, Bansal SS, Campostrini N, Drakesmith H, Fillet M, Olbina G, Pasricha SR, Pitts KR, Sloan JH, Tagliaro F, Weykamp CW, Swinkels DW. Toward worldwide hepcidin assay harmonization: identification of a commutable secondary reference material. Clin Chem. 2016;62:993\u20131001.", "ArticleIdList": ["27173010"]}, {"Citation": "Traglia M, Girelli D, Biino G, Campostrini N, Corbella M, Sala C, Masciullo C, Vigan\u00f2 F, Buetti I, Pistis G, Cocca M, Camaschella C, Toniolo D. Association of HFE and TMPRSS6 genetic variants with iron and erythrocyte parameters is only in part dependent on serum hepcidin concentrations. J Med Genet. 2011;48:629\u2013634.", "ArticleIdList": ["21785125"]}, {"Citation": "Martinelli N, Traglia M, Campostrini N, Biino G, Corbella M, Sala C, Busti F, Masciullo C, Manna D, Previtali S, Castagna A, Pistis G, Olivieri O, Toniolo D, Camaschella C, Girelli D. Increased serum hepcidin levels in subjects with the metabolic syndrome: a population study. PLoS One. 2012;7:e48250. Erratum in: PLoS One. 2013;8:null.", "ArticleIdList": ["PMC3483177", "23144745"]}, {"Citation": "Galesloot TE, Vermeulen SH, Geurts-Moespot AJ, Klaver SM, Kroot JJ, van Tienoven D, Wetzels JF, Kiemeney LA, Sweep FC, den Heijer M, Swinkels DW. Serum hepcidin: reference ranges and biochemical correlates in the general population. Blood. 2011;117:e218\u2013225.", "ArticleIdList": ["21527524"]}, {"Citation": "Jallow MW, Campino S, Prentice AM, Cerami C. Association of common TMPRSS6 and TF gene variants with hepcidin and iron status in healthy rural Gambians. Sci Rep. 2021;11:8075.", "ArticleIdList": ["PMC8044158", "33850216"]}, {"Citation": "Pechlaner R, Kiechl S, Mayr M, Santer P, Weger S, Haschka D, Bansal SS, Willeit J, Weiss G. Correlates of serum hepcidin levels and its association with cardiovascular disease in an elderly general population. Clin Chem Lab Med. 2016;54:151\u2013161.", "ArticleIdList": ["26124055"]}, {"Citation": "Troutt JS, Rudling M, Persson L, St\u00e5hle L, Angelin B, Butterfield AM, Schade AE, Cao G, Konrad RJ. Circulating human hepcidin-25 concentrations display a diurnal rhythm, increase with prolonged fasting, and are reduced by growth hormone administration. Clin Chem. 2012;58:1225\u20131232.", "ArticleIdList": ["22679180"]}, {"Citation": "Kroot JJ, Hendriks JC, Laarakkers CM, Klaver SM, Kemna EH, Tjalsma H, Swinkels DW. (Pre)analytical imprecision, between-subject variability, and daily variations in serum and urine hepcidin: implications for clinical studies. Anal Biochem. 2009;389:124\u2013129.", "ArticleIdList": ["19341701"]}, {"Citation": "Itkonen O, Parkkinen J, Stenman UH, H\u00e4m\u00e4l\u00e4inen E. Preanalytical factors and reference intervals for serum hepcidin LC-MS/MS method. Clin Chim Acta. 2012;413:696\u2013701.", "ArticleIdList": ["22222553"]}, {"Citation": "Laarakkers CM, Wiegerinck ET, Klaver S, Kolodziejczyk M, Gille H, Hohlbaum AM, Tjalsma H, Swinkels DW. Improved mass spectrometry assay for plasma hepcidin: detection and characterization of a novel hepcidin isoform. PLoS One. 2013;8:e75518.", "ArticleIdList": ["PMC3790851", "24124495"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "11", "Day": "1", "Hour": "9", "Minute": "36"}, {"Year": "2022", "Month": "11", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "11", "Day": "2", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "10", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["36317954", "PMC9634449", "10.4274/tjps.galenos.2021.29488"]}}], "PubmedBookArticle": []}